title: Chitosan phthalate microspheres for oral delivery of insulin: preparation, characterization, and in vitro evaluation.
abstract: Chitosan phthalate polymer was synthesized and its microspheres were prepared by emulsion phase separation technique. The characterization of microspheres was determined by means of FTIR spectroscopy, electron microscopy, particle size, and zeta potential. The insulin was loaded to the microspheres by passive absorption technique. The peptic and tryptic enzymes degradation of insulin in microspheres was investigated. The in vitro release behavior of the microspheres was investigated under different pH conditions (pH 2.0 and pH 7.4). The degree of phthalate substitution in the synthesized polymer was 20%. The prepared microspheres were spherical with an average diameter 46.34 micro m. The insulin-loading capacity was 62%. Chitosan phthalate microspheres protect the insulin from gastric enzymes degradation that may enhance the oral stability of insulin. The encapsulated insulin was quickly released in a phosphate buffer saline (pH 7.4), whereas a small amount of insulin was released under acidic condition (0.1N HCl; pH 2.0) because under acidic conditions, carboxylic groups present in the system exist in nonionized form and are poorly hydrophilic. However, in alkaline conditions, it exists in ionized form and is considerably hydrophilic. The results suggest that chitosan phthalate microspheres may be used as a potential carrier for oral insulin delivery.
authors.affiliation: Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi, India. ubaidnkl@yahoo.com
authors.forename: U
authors.initials: U
authors.lastname: Ubaidulla
authors.forename: Y
authors.initials: Y
authors.lastname: Sultana
authors.forename: F J
authors.initials: FJ
authors.lastname: Ahmed
authors.forename: R K
authors.initials: RK
authors.lastname: Khar
authors.forename: A K
authors.initials: AK
authors.lastname: Panda
mesh_terms: D000284:Administration, Oral; D048271:Chitosan / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D004339:Drug Compounding; D004563:Electrochemistry; D004591:Electrophoresis, Polyacrylamide Gel; D004655:Emulsions; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000737:chemistry; D007328:Insulin / Q000008:administration & dosage* / Q000737:chemistry; D008863:Microspheres; D010316:Particle Size; D010434:Pepsin A / Q000737:chemistry; D013055:Spectrophotometry, Infrared; D014357:Trypsin / Q000737:chemistry
chemical_list: D004655:Emulsions; D007004:Hypoglycemic Agents; D007328:Insulin; C119691:chitosan phthalate; D048271:Chitosan; D014357:Trypsin; D010434:Pepsin A